These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2482551)

  • 1. Characterization of a monoclonal antibody recognizing a polymorphic epitope mainly on HLA-DPw2 and DPw4 molecules.
    Viken HD; Gaudernack G; Thorsby E
    Tissue Antigens; 1989 Oct; 34(4):250-9. PubMed ID: 2482551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A newly characterized HLA-DP beta-chain allele. Evidence for DP beta heterogeneity within the DPw4 specificity.
    Lair B; Alber C; Yu WY; Watts R; Bahl M; Karr RW
    J Immunol; 1988 Aug; 141(4):1353-7. PubMed ID: 2456351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to HLA-DP-transfected mouse L cells.
    Heyes J; Austin P; Bodmer J; Bodmer W; Madrigal A; Mazzilli MC; Trowsdale J
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3417-21. PubMed ID: 3517859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope recognition by a DP alpha chain-specific monoclonal antibody (DP11.1) is influenced by the interaction between the DP alpha chain and its polymorphic DP beta chain partner.
    Young JA; Lindsay J; Bodmer JG; Trowsdale J
    Hum Immunol; 1988 Sep; 23(1):37-44. PubMed ID: 2461352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of HLA-DP specificities HLA-DPw1, -DPw2 and -DPw4: DP beta chain heterogeneity correlates with PLT subtyping.
    Baas EJ; Bontrop RE; Otting N; Giphart MJ
    Tissue Antigens; 1988 Jan; 31(1):5-13. PubMed ID: 2829386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological detection and molecular localization of allelic HLA-DP supertypic epitopes.
    Colonna M; Tanigaki N; Tosi R; Ferrara GB
    Eur J Immunol; 1989 Mar; 19(3):433-40. PubMed ID: 2468502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
    Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW
    J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New polymorphic HLA-DR epitopes recognized by three monoclonal antibodies produced against DR103 transfected L cells.
    Cayrol C; Moro F; Sommer E; Tkaczuk J; Ohayon E; Cambon-Thomsen A
    Tissue Antigens; 1992 Oct; 40(4):197-203. PubMed ID: 1281933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DP epitope typing using monoclonal antibodies.
    Marshall WH; Drover S; Codner D; Gamberg J; Copp MD; Liu HW; Deng LT; Younghusband HB
    Hum Immunol; 1998 Mar; 59(3):189-97. PubMed ID: 9548079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of transfectants to characterize a monoclonal antibody recognizing a monomorphic DR beta-chain epitope shared by some DQ and DP molecules.
    Cayrol C; Moro F; Tkaczuk J; Cambon-Thomsen A
    Tissue Antigens; 1993 Apr; 41(4):196-9. PubMed ID: 7689765
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization and epitope mapping of four HLA class II reactive mouse monoclonal antibodies using transfected L cells and human cells transfected with mutants of DQB1*0302.
    Viken HD; Thorsby E; Gaudernack G
    Tissue Antigens; 1995 Apr; 45(4):250-7. PubMed ID: 7638861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of murine monoclonal antibodies recognizing HLA-DQ polymorphisms obtained by immunizing mice with transfected L cells.
    Vitale M; Pistillo MP; Tazzari PL; Falco M; Sun PF; Mantero S; Ferrara GB
    Hum Immunol; 1992 Jun; 34(2):126-34. PubMed ID: 1429033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in specificity of "DPw2-specific" cytotoxic T cell clones revealed with HLA-mutant lines: evidence that non-DP HLA genes influence recognition by some clones.
    Sánchez Pérez M; Diez Orejas R; Petersen JW; De Mars R; Shaw S
    Eur J Immunol; 1990 Mar; 20(3):673-81. PubMed ID: 2108045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DPbeta residue 69 plays a crucial role in allorecognition.
    Díaz G; Catálfamo M; Coiras MT; Alvarez AM; Jaraquemada D; Nombela C; Sánchez-Pérez M; Arroyo J
    Tissue Antigens; 1998 Jul; 52(1):27-36. PubMed ID: 9714471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A murine monoclonal antibody (928) recognizing a new epitope formed with a combination of HLA-DPA1*0201 and DPB1*0301 gene products.
    Kishi H; Okumura A; Tong JJ; Sugiyama E; Matsuno H; Minowada J; Kanai T; Nishimura Y; Muraguchi A
    Hum Immunol; 1997; 56(1-2):114-24. PubMed ID: 9455500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linking of a sequential epitope within the beta-chain of HLA-DR/DP molecules suppressing B lymphocyte growth and inducing homotypic cell aggregation.
    Ghaderi AA; Gaudernack G; Stanworth DR
    Immunol Lett; 1994 Feb; 39(2):113-9. PubMed ID: 7516911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of HLA-DP allelic sequence polymorphism using the in vitro enzymatic DNA amplification of DP-alpha and DP-beta loci.
    Bugawan TL; Horn GT; Long CM; Mickelson E; Hansen JA; Ferrara GB; Angelini G; Erlich HA
    J Immunol; 1988 Dec; 141(11):4024-30. PubMed ID: 2460556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RG1, a new murine monoclonal antibody recognizing a "supertypic" determinant on HLA-A molecules.
    Pettersen RD; Hestdal K; Lee N; Geraghty DE; Valø ET; Lie SO; Gaudernack G
    Tissue Antigens; 1995 Mar; 45(3):203-12. PubMed ID: 7539160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A supertypic HLA-DP specificity defined by two human-human hybridoma antibodies (TrB50; TrE11).
    Kolstad A; Hannestad K
    Hum Immunol; 1989 Aug; 25(4):247-56. PubMed ID: 2788637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mAb KUL/05 identifies a denaturation-resistant determinant shared by class II MHC products DR, DQ and DP.
    Giacomini P; Tecce R; Nicotra MR; Cohen BB; Mazzilli MC; Natali PG
    J Immunogenet; 1989 Jun; 16(3):203-16. PubMed ID: 2482314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.